In a first for the Big Pharma and as part of a new model, Pfizer is taking drugs from its shelves and licensing them to, while investing in, its SpringWorks Therapeutics startup.
{iframe}http://www.fiercebiotech.com/biotech/pfizer-launches-new-upstart-103m-phase-3-ready-meds{/iframe}